Author | Bryden Considine, DO

Articles

Novel Targets and Precision Medicine for Prostate Cancer-Part 2: Tumor Profiling and Personalized Therapy in Patients With Castration-Resistant Prostate Cancer

April 15, 2019

In this article, we review the current use of and future direction for genetic testing and tumor profiling in patients with metastatic castration-resistant prostate cancer.

Integrating Novel Targets and Precision Medicine Into Prostate Cancer Care-Part 1: The Non-Androgen–Targetable Pathways in Castration-Resistant Prostate Cancer

March 13, 2019

Here, we review the current use and future direction of novel therapeutic targets in the treatment of castration-resistant prostate cancer.